Sanara MedTech Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
3analysts covering
FY Revenue (est.)
$117.7Mnext fiscal year
FY EPS (est.)
$0.18next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 12 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Net Revenue Annually103.1MTarget: $116,000,000 to $121,000,000
Gross Margin Quarterly93.0%Target: Maintain >90%
Adjusted EBITDA Quarterly4.3MTarget: Continued expansion and operating leverage
Watch Items
- OsStic FDA Clearance and Commercial LaunchTrigger: FDA clearance expected ahead of Q1 2027 launchAction: Monitor regulatory filings and strategic alliance updates with Biomimetic Innovations Ltd
- Debt Service CoverageTrigger: Net interest cover at 1.5xAction: Evaluate cash flow generation and potential debt refinancing opportunities in 2026
Research as of 20 Jun 2026